Sorry, you need to enable JavaScript to visit this website.
Skip to main content


Eribulin Mesylate

Therapeutic Category
Anti-Cancer/ Oncology
API Technology
Synthetic
Dose From
Injectable
Dr Reddy's Development Status
Under-Development
Innovator Brand (USA)
HALAVEN

We are here to help, if you have any country specific requirements - please Contact Us.